Page last updated: 2024-08-25

voriconazole and Otomycosis

voriconazole has been researched along with Otomycosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Bouatay, R; Ferjaoui, M; Harrathi, K; Houas, J; Kolsi, N; Korbi, AE; Koubaa, J; Toumi, A1
Fatahinia, M; Halvaeezadeh, M; Jalaee, GA; Mahmoudabadi, AZ1
Hu, S; Jin, M; Zhang, S; Zhang, Y; Zhou, G1
Hsueh, PR; Jing, R; Li, XW; Li, Y; Wang, CY; Xiao, M; Xu, YC; Yang, WH; Zou, GL1
Chappe, M; de Gentile, L; Lagarce, F; Le Govic, Y; Legrand, G; Vrignaud, S1
Ho, HC; Hsiao, SH; Lee, CY; Tsai, CC1

Reviews

1 review(s) available for voriconazole and Otomycosis

ArticleYear
Treatment of refractory Aspergillus otomycosis with voriconazole: case series and review.
    The Journal of laryngology and otology, 2014, Volume: 128, Issue:6

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Chronic Disease; Female; Humans; Male; Middle Aged; Otomycosis; Voriconazole; Young Adult

2014

Other Studies

5 other study(ies) available for voriconazole and Otomycosis

ArticleYear
Fungal necrotizing external otitis: diagnosis, management and outcomes of 15 cases.
    The Pan African medical journal, 2022, Volume: 42

    Topics: Abscess; Aged; Antifungal Agents; Candida; Female; Humans; Male; Otitis Externa; Otomycosis; Voriconazole

2022
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
    Microbial pathogenesis, 2023, Volume: 181

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Calmodulin; Female; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Nystatin; Otomycosis; Voriconazole

2023
Administration of 1% topical voriconazole drops was effective and safe in the treatment of refractory otomycosis without tympanic membrane perforation.
    The Annals of otology, rhinology, and laryngology, 2021, Volume: 130, Issue:3

    Topics: Administration, Topical; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Audiometry, Pure-Tone; Culture Techniques; Earache; Female; Hearing Loss; Humans; Male; Middle Aged; Otomycosis; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult

2021
Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2022, Volume: 55, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Otomycosis; Voriconazole

2022
Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Administration, Topical; Antifungal Agents; Aspergillosis; Aspergillus niger; Cerumen; Female; Humans; Middle Aged; Nystatin; Otomycosis; Prospective Studies; Treatment Outcome; Voriconazole

2018